DURYSTA™ (bimatoprost implant) Reimbursement–Product Specific J-code (J7351) Is Here!

Date: November 5, 2020

Time: 03:00PM - 04:15PM

You must be registered to participate!

Synopsis:

This session addresses new and timely information for DURYSTA™ reimbursement, specifically, the product-specific J-code for DURYSTA™ (J7351). Join to learn about the billing process for the new J-code, payer coverage, practice operation, and reimbursement considerations to remove barriers and provide access to care for your DURYSTA™ patients. In addition, explore DURYSTA™ procurement avenues such as buy and bill and specialty pharmacy.

Learning Objectives:

  • Evaluate your DURYSTA™ reimbursement processes
  • Learn about DURYSTA™ billing, coding, and payer coverage

Presented by Allergan, an AbbVie company

custom image


© 2020 AbbVie. All rights reserved. All trademarks are the property of their respective owners.

Speakers:
  • Meg Gilson, Chief Clinical Officer, Eye Surgeons Associates, Illinois and Iowa

DUR141163 10/20